• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪肝疾病、女性与醛固酮:在杰克逊心脏研究中寻找关联

Fatty Liver Disease, Women, and Aldosterone: Finding a Link in the Jackson Heart Study.

作者信息

Kumar Aditi, Blackshear Chad, Subauste Jose S, Esfandiari Nazanene H, Oral Elif Arioglu, Subauste Angela R

机构信息

Department of Medicine, Division of Endocrinology, University of Mississippi Medical Center, Jackson, Mississippi, 39216.

Center of Biostatistics and Bioinformatics, University of Mississippi Medical Center, Jackson, Mississippi, 39216.

出版信息

J Endocr Soc. 2017 Mar 22;1(5):460-469. doi: 10.1210/js.2017-00055. eCollection 2017 May 1.

DOI:10.1210/js.2017-00055
PMID:29264501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5686785/
Abstract

CONTEXT

Fatty liver disease is one of the most common forms of chronic liver disease. The renin-angiotensin-aldosterone system has been implicated in the pathogenesis of fatty liver.

OBJECTIVE

Determine the relationship between fatty liver and aldosterone in a large cohort study.

DESIGN

Community-based, observational cohort study of African Americans.

SETTING

The original Jackson Heart Study cohort enrolled African American participants from the Jackson, Mississippi, metropolitan area in Hinds, Madison, and Rankin Counties.

PARTICIPANTS

Our study population consisted of 2507 Jackson Heart Study participants (1625 women and 882 men) who had liver attenuation measured per computed tomography scans, had aldosterone measurements, and were not taking angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or mineralocorticoid receptor antagonists.

INTERVENTION

There was no intervention.

MAIN OUTCOME MEASURE

Liver attenuation on computed tomography scans.

RESULTS

Univariate regression analysis demonstrated a statistically significant correlation between aldosterone levels and liver attenuation. Each doubling of aldosterone was associated with 1.08 Hounsfield unit decrease (95% confidence interval, 1.47 to -0.69, < 0.001). A multivariable model adjusted for body mass index, age, alcohol intake, and homeostatic model assessment of insulin resistance determined that the association was statistically significant only for women.

CONCLUSION

Our data demonstrate a positive association between aldosterone levels and fatty liver in African American women.

摘要

背景

脂肪性肝病是最常见的慢性肝病形式之一。肾素-血管紧张素-醛固酮系统与脂肪性肝病的发病机制有关。

目的

在一项大型队列研究中确定脂肪性肝病与醛固酮之间的关系。

设计

基于社区的非裔美国人观察性队列研究。

地点

最初的杰克逊心脏研究队列招募了来自密西西比州杰克逊市大都市地区辛兹县、麦迪逊县和兰金县的非裔美国参与者。

参与者

我们的研究人群包括2507名杰克逊心脏研究参与者(1625名女性和882名男性),他们通过计算机断层扫描测量了肝脏衰减,进行了醛固酮测量,且未服用血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂或盐皮质激素受体拮抗剂。

干预措施

无干预。

主要观察指标

计算机断层扫描上的肝脏衰减。

结果

单变量回归分析显示醛固酮水平与肝脏衰减之间存在统计学显著相关性。醛固酮每增加一倍,肝脏衰减就会降低1.08亨氏单位(95%置信区间为1.47至-0.69,P<0.001)。在对体重指数、年龄、酒精摄入量和胰岛素抵抗的稳态模型评估进行调整的多变量模型中,该关联仅在女性中具有统计学显著性。

结论

我们的数据表明非裔美国女性的醛固酮水平与脂肪性肝病之间存在正相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf3/5686785/4dcb1c039dfd/js-01-460-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf3/5686785/4dcb1c039dfd/js-01-460-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf3/5686785/4dcb1c039dfd/js-01-460-f1.jpg

相似文献

1
Fatty Liver Disease, Women, and Aldosterone: Finding a Link in the Jackson Heart Study.脂肪肝疾病、女性与醛固酮:在杰克逊心脏研究中寻找关联
J Endocr Soc. 2017 Mar 22;1(5):460-469. doi: 10.1210/js.2017-00055. eCollection 2017 May 1.
2
Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study.非裔美国人中的醛固酮、肾素与糖尿病:杰克逊心脏研究
J Clin Endocrinol Metab. 2016 Apr;101(4):1770-8. doi: 10.1210/jc.2016-1002. Epub 2016 Feb 23.
3
Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.正在发生心原性休克患者中早期心力衰竭药物治疗的发生率和结局。
Crit Care Med. 2014 Feb;42(2):281-8. doi: 10.1097/CCM.0b013e31829f6242.
4
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.男性和女性心力衰竭患者中血管紧张素转换酶 2 的循环血浆浓度及其对肾素-血管紧张素-醛固酮抑制剂的影响。
Eur Heart J. 2020 May 14;41(19):1810-1817. doi: 10.1093/eurheartj/ehaa373.
5
The renin-angiotensin-aldosterone system and heart failure.肾素-血管紧张素-醛固酮系统与心力衰竭。
Cardiol Clin. 2014 Feb;32(1):21-32, vii. doi: 10.1016/j.ccl.2013.09.002.
6
Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?肾素-血管紧张素-醛固酮系统抑制:在心脏-肾脏连续统中是否有双重阻断的空间?
J Hypertens. 2012 Apr;30(4):647-54. doi: 10.1097/HJH.0b013e32834f6e00.
7
Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease.患有自然发生的黏液瘤性二尖瓣疾病的犬类中的醛固酮突破
J Vet Cardiol. 2017 Jun;19(3):218-227. doi: 10.1016/j.jvc.2017.03.001. Epub 2017 May 31.
8
Hypertension: renin-angiotensin-aldosterone system alterations.高血压:肾素-血管紧张素-醛固酮系统改变。
Circ Res. 2015 Mar 13;116(6):960-75. doi: 10.1161/CIRCRESAHA.116.303587.
9
The effects of aldosterone on diet-induced fatty liver formation in male C57BL/6 mice: comparison of adrenalectomy and mineralocorticoid receptor blocker.醛固酮对雄性C57BL/6小鼠饮食诱导性脂肪肝形成的影响:肾上腺切除术与盐皮质激素受体阻滞剂的比较
Eur J Gastroenterol Hepatol. 2013 Sep;25(9):1086-92. doi: 10.1097/MEG.0b013e328360554a.
10
β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.对于长期接受治疗的高血压患者,为准确解读醛固酮-肾素比值,停用β受体阻滞剂更为可取。
Clin Endocrinol (Oxf). 2016 Mar;84(3):325-31. doi: 10.1111/cen.12882. Epub 2015 Sep 22.

引用本文的文献

1
The Role of Aldosterone and the Mineralocorticoid Receptor in Metabolic Dysfunction-Associated Steatotic Liver Disease.醛固酮和盐皮质激素受体在代谢功能障碍相关脂肪性肝病中的作用
Biomedicines. 2025 Jul 22;13(8):1792. doi: 10.3390/biomedicines13081792.
2
Associating plasma aldosterone concentration with the prevalence of MAFLD in hypertensive patients: insights from a large-scale cross-sectional study.血浆醛固酮浓度与高血压患者 MAFLD 患病率的相关性:一项大规模横断面研究的启示。
Front Endocrinol (Lausanne). 2024 Sep 19;15:1451383. doi: 10.3389/fendo.2024.1451383. eCollection 2024.
3
Adiposity, aldosterone and plasma renin activity among African Americans: The Jackson Heart Study.

本文引用的文献

1
Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-Up.醛固酮可预测普通人群中的心血管、肾脏和代谢性疾病:一项4年随访研究。
J Am Heart Assoc. 2015 Dec 23;4(12):e002505. doi: 10.1161/JAHA.115.002505.
2
Angiotensinogen Exerts Effects Independent of Angiotensin II.血管紧张素原发挥独立于血管紧张素II的作用。
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):256-65. doi: 10.1161/ATVBAHA.115.306740. Epub 2015 Dec 17.
3
Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.
非裔美国人的肥胖、醛固酮与血浆肾素活性:杰克逊心脏研究
Endocr Metab Sci. 2023 Jun 30;11. doi: 10.1016/j.endmts.2023.100126. Epub 2023 Apr 17.
4
Relationship Between Plasma Aldosterone Concentrations and Non-Alcoholic Fatty Liver Disease Diagnosis in Patients with Hypertension: A Retrospective Cohort Study.高血压患者血浆醛固酮浓度与非酒精性脂肪性肝病诊断之间的关系:一项回顾性队列研究
Diabetes Metab Syndr Obes. 2023 Jun 6;16:1625-1636. doi: 10.2147/DMSO.S408722. eCollection 2023.
5
Nonalcoholic Fatty Liver Disease and Endocrine Axes-A Scoping Review.非酒精性脂肪性肝病与内分泌轴——一项范围综述
Metabolites. 2022 Mar 29;12(4):298. doi: 10.3390/metabo12040298.
6
Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population.原发性醛固酮增多症患者中非酒精性脂肪性肝病与低钾血症。
Front Endocrinol (Lausanne). 2021 Apr 22;12:565714. doi: 10.3389/fendo.2021.565714. eCollection 2021.
7
Benchmark Concentrations for Untargeted Metabolomics Versus Transcriptomics for Liver Injury Compounds in In Vitro Liver Models.体外肝模型中肝损伤化合物的非靶向代谢组学与转录组学的基准浓度
Toxicol Sci. 2021 May 27;181(2):175-186. doi: 10.1093/toxsci/kfab036.
8
The Effects of Continual Consumption of on Liver Transcriptomics.持续食用……对肝脏转录组学的影响。 (注:原文中“of”后面缺少具体内容)
Animals (Basel). 2021 Feb 4;11(2):398. doi: 10.3390/ani11020398.
9
Unanticipated increases in hepatic steatosis among human immunodeficiency virus patients receiving mineralocorticoid receptor antagonist eplerenone for non-alcoholic fatty liver disease.人类免疫缺陷病毒患者在接受非酒精性脂肪性肝病治疗时使用盐皮质激素受体拮抗剂依普利酮,会出现非预期的肝脂肪变性增加。
Liver Int. 2018 May;38(5):797-802. doi: 10.1111/liv.13734. Epub 2018 Mar 31.
盐皮质激素受体阻断在实验性非酒精性脂肪性肝炎中的有益作用。
Liver Int. 2015 Sep;35(9):2129-38. doi: 10.1111/liv.12794. Epub 2015 Feb 23.
4
Nonalcoholic fatty liver disease and aging: epidemiology to management.非酒精性脂肪性肝病与衰老:从流行病学到管理
World J Gastroenterol. 2014 Oct 21;20(39):14185-204. doi: 10.3748/wjg.v20.i39.14185.
5
Ethnic and sex differences in fatty liver on cardiac computed tomography: the multi-ethnic study of atherosclerosis.心脏计算机断层扫描中的脂肪肝的种族和性别差异:动脉粥样硬化的多民族研究。
Mayo Clin Proc. 2014 Apr;89(4):493-503. doi: 10.1016/j.mayocp.2013.12.015. Epub 2014 Mar 7.
6
The global NAFLD epidemic.全球非酒精性脂肪性肝病流行状况。
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):686-90. doi: 10.1038/nrgastro.2013.171. Epub 2013 Sep 17.
7
Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY).替米沙坦或氯沙坦治疗非酒精性脂肪性肝病的效果:替米沙坦或氯沙坦脂肪肝保护试验(FANTASY)。
Int J Endocrinol. 2013;2013:587140. doi: 10.1155/2013/587140. Epub 2013 Aug 13.
8
Serum potassium level is associated with metabolic syndrome: a population-based study.血清钾水平与代谢综合征有关:一项基于人群的研究。
Clin Nutr. 2014 Jun;33(3):521-7. doi: 10.1016/j.clnu.2013.07.010. Epub 2013 Jul 17.
9
Nonalcoholic fatty liver disease and the renin-angiotensin system: Implications for treatment.非酒精性脂肪性肝病与肾素-血管紧张素系统:对治疗的启示
World J Hepatol. 2012 Dec 27;4(12):327-31. doi: 10.4254/wjh.v4.i12.327.
10
The role of angiotensin II in nonalcoholic steatohepatitis.血管紧张素 II 在非酒精性脂肪性肝炎中的作用。
Mol Cell Endocrinol. 2013 Sep 25;378(1-2):29-40. doi: 10.1016/j.mce.2012.04.013. Epub 2012 May 11.